| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 44,844 | 45,429 | 44,658 | 23,303 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 45,429 | 44,658 | 23,303 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 36,527 | 37,270 | 34,314 | 39,251 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 5,249 | 4,538 | 4,558 | 4,863 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,068 | 3,621 | 5,786 | (20,811) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 3,068 | 3,621 | 5,786 | (20,811) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 3,068 | 3,621 | 5,786 | (20,811) | | Income Tax Expense | 820 | 905 | 1,409 | (191) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,248 | 2,716 | 4,377 | (20,620) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,248 | 2,716 | 4,377 | (20,620) | | Preferred Stock And Other Adjustments |
-
| (2,348) |
-
|
-
| | | Net Income Applicable To Common Shares | $2,091 | $368 | $4,377 | ($20,620) |
|
0.03% Nasdaq 0.00%
Income Statement
